Technical Analysis for IPHA - Innate Pharma S.A.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 2.71 | 5.28% | 0.14 |
IPHA closed up 5.28 percent on Friday, May 17, 2024, on 1.25 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 200 DMA | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Stochastic Sell Signal | Bearish | 5.28% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 5.28% | |
| NR7 | Range Contraction | 5.28% | |
| Narrow Range Bar | Range Contraction | 5.28% |
| Alert | Time |
|---|---|
| Up 5% | 1 day ago |
| Possible Pocket Pivot | 2 days ago |
| 60 Minute Opening Range Breakout | 2 days ago |
| 2x Volume Pace | 2 days ago |
| 1.5x Volume Pace | 2 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/14/2024
Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. The Monoclonal antibodies targets receptors and pathways controlling the activation of innate immunity cells. The company was founded by Hervé Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié and François Romagné on September 15, 1999 and is headquartered in Marseille, France.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Immunology Immune System Immunotherapy Antibodies Cancer Treatment Monoclonal Antibodies Monoclonal Antibody Antibody Inflammatory Diseases Immunity
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Immunology Immune System Immunotherapy Antibodies Cancer Treatment Monoclonal Antibodies Monoclonal Antibody Antibody Inflammatory Diseases Immunity
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.57 |
| 52 Week Low | 1.81 |
| Average Volume | 9,975 |
| 200-Day Moving Average | 2.61 |
| 50-Day Moving Average | 2.51 |
| 20-Day Moving Average | 2.51 |
| 10-Day Moving Average | 2.58 |
| Average True Range | 0.15 |
| RSI (14) | 57.81 |
| ADX | 19.7 |
| +DI | 25.52 |
| -DI | 15.09 |
| Chandelier Exit (Long, 3 ATRs) | 2.27 |
| Chandelier Exit (Short, 3 ATRs) | 2.69 |
| Upper Bollinger Bands | 2.70 |
| Lower Bollinger Band | 2.32 |
| Percent B (%b) | 1.02 |
| BandWidth | 15.28 |
| MACD Line | 0.03 |
| MACD Signal Line | 0.02 |
| MACD Histogram | 0.0186 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.83 | ||||
| Resistance 3 (R3) | 2.82 | 2.76 | 2.81 | ||
| Resistance 2 (R2) | 2.76 | 2.73 | 2.77 | 2.80 | |
| Resistance 1 (R1) | 2.74 | 2.71 | 2.75 | 2.75 | 2.80 |
| Pivot Point | 2.68 | 2.68 | 2.69 | 2.69 | 2.68 |
| Support 1 (S1) | 2.66 | 2.65 | 2.67 | 2.67 | 2.62 |
| Support 2 (S2) | 2.60 | 2.63 | 2.61 | 2.62 | |
| Support 3 (S3) | 2.58 | 2.60 | 2.61 | ||
| Support 4 (S4) | 2.59 |
